Mucosal immunity and primary biliary cirrhosis

Presence of antimitochondrial antibodies in urine

Atsushi Tanaka, Gregory Nalbandian, Patrick S Leung, Gordon D. Benson, Santiago Munoz, Jorge A. Findor, Andrea D. Branch, Ross L. Coppel, Aftab A. Ansari, M. Eric Gershwin

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

We have shown that IgA-class antimitochondrial autoantibodies (AMA) can be detected in the bile and saliva of patients with PBC, suggesting that AMA are secreted into the luminal fluid across bile ducts and salivary glands. These data prompted us to determine whether AMA of the IgA isotype may be transported across other epithelial mucosa. Therefore, we tested for the presence of AMA in the urine specimens of 83 patients with PBC and 58 non-PBC controls including healthy individuals and patients with other liver diseases. Patients enrolled in this study had no history of renal disease, and we confirmed there was less than 50 μg/mL of protein in each of the urine specimens. Interestingly, we found that AMA were present in the urine of 71/83 (86%) of all patients with PBC and in 71/78 (91%) of patients with PBC that were serum AMA positive. In contrast, AMA were not detected in any of the 58 control urine specimens. Of particular interest, AMA of the IgA isotype was present in 57/83 (69%) of patients with PBC, and in 52 of these 57, we found secretory-type IgA. In a nested random subgroup of urine samples, the prevalence of the IgA2 AMA was 6/18 (33%), significantly lower than in matched serum samples, 13/16 (81%, P = .007). These data show that AMA of the IgA isotype is secreted into urine from the uroepithelium of patients with PBC, and support the thesis that PBC originated from either a mucosal challenge or a loss of mucosal tolerance.

Original languageEnglish (US)
Pages (from-to)910-915
Number of pages6
JournalHepatology
Volume32
Issue number5
StatePublished - 2000

Fingerprint

Mucosal Immunity
Biliary Liver Cirrhosis
Autoantibodies
Urine
Antibodies
Immunoglobulin A
Secretory Immunoglobulin A
Bile Ducts
Salivary Glands
Serum
Saliva
Bile
Liver Diseases
Mucous Membrane
Kidney

ASJC Scopus subject areas

  • Hepatology

Cite this

Tanaka, A., Nalbandian, G., Leung, P. S., Benson, G. D., Munoz, S., Findor, J. A., ... Gershwin, M. E. (2000). Mucosal immunity and primary biliary cirrhosis: Presence of antimitochondrial antibodies in urine. Hepatology, 32(5), 910-915.

Mucosal immunity and primary biliary cirrhosis : Presence of antimitochondrial antibodies in urine. / Tanaka, Atsushi; Nalbandian, Gregory; Leung, Patrick S; Benson, Gordon D.; Munoz, Santiago; Findor, Jorge A.; Branch, Andrea D.; Coppel, Ross L.; Ansari, Aftab A.; Gershwin, M. Eric.

In: Hepatology, Vol. 32, No. 5, 2000, p. 910-915.

Research output: Contribution to journalArticle

Tanaka, A, Nalbandian, G, Leung, PS, Benson, GD, Munoz, S, Findor, JA, Branch, AD, Coppel, RL, Ansari, AA & Gershwin, ME 2000, 'Mucosal immunity and primary biliary cirrhosis: Presence of antimitochondrial antibodies in urine', Hepatology, vol. 32, no. 5, pp. 910-915.
Tanaka A, Nalbandian G, Leung PS, Benson GD, Munoz S, Findor JA et al. Mucosal immunity and primary biliary cirrhosis: Presence of antimitochondrial antibodies in urine. Hepatology. 2000;32(5):910-915.
Tanaka, Atsushi ; Nalbandian, Gregory ; Leung, Patrick S ; Benson, Gordon D. ; Munoz, Santiago ; Findor, Jorge A. ; Branch, Andrea D. ; Coppel, Ross L. ; Ansari, Aftab A. ; Gershwin, M. Eric. / Mucosal immunity and primary biliary cirrhosis : Presence of antimitochondrial antibodies in urine. In: Hepatology. 2000 ; Vol. 32, No. 5. pp. 910-915.
@article{fdeaf4e5c54e488fb77015167218228a,
title = "Mucosal immunity and primary biliary cirrhosis: Presence of antimitochondrial antibodies in urine",
abstract = "We have shown that IgA-class antimitochondrial autoantibodies (AMA) can be detected in the bile and saliva of patients with PBC, suggesting that AMA are secreted into the luminal fluid across bile ducts and salivary glands. These data prompted us to determine whether AMA of the IgA isotype may be transported across other epithelial mucosa. Therefore, we tested for the presence of AMA in the urine specimens of 83 patients with PBC and 58 non-PBC controls including healthy individuals and patients with other liver diseases. Patients enrolled in this study had no history of renal disease, and we confirmed there was less than 50 μg/mL of protein in each of the urine specimens. Interestingly, we found that AMA were present in the urine of 71/83 (86{\%}) of all patients with PBC and in 71/78 (91{\%}) of patients with PBC that were serum AMA positive. In contrast, AMA were not detected in any of the 58 control urine specimens. Of particular interest, AMA of the IgA isotype was present in 57/83 (69{\%}) of patients with PBC, and in 52 of these 57, we found secretory-type IgA. In a nested random subgroup of urine samples, the prevalence of the IgA2 AMA was 6/18 (33{\%}), significantly lower than in matched serum samples, 13/16 (81{\%}, P = .007). These data show that AMA of the IgA isotype is secreted into urine from the uroepithelium of patients with PBC, and support the thesis that PBC originated from either a mucosal challenge or a loss of mucosal tolerance.",
author = "Atsushi Tanaka and Gregory Nalbandian and Leung, {Patrick S} and Benson, {Gordon D.} and Santiago Munoz and Findor, {Jorge A.} and Branch, {Andrea D.} and Coppel, {Ross L.} and Ansari, {Aftab A.} and Gershwin, {M. Eric}",
year = "2000",
language = "English (US)",
volume = "32",
pages = "910--915",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Mucosal immunity and primary biliary cirrhosis

T2 - Presence of antimitochondrial antibodies in urine

AU - Tanaka, Atsushi

AU - Nalbandian, Gregory

AU - Leung, Patrick S

AU - Benson, Gordon D.

AU - Munoz, Santiago

AU - Findor, Jorge A.

AU - Branch, Andrea D.

AU - Coppel, Ross L.

AU - Ansari, Aftab A.

AU - Gershwin, M. Eric

PY - 2000

Y1 - 2000

N2 - We have shown that IgA-class antimitochondrial autoantibodies (AMA) can be detected in the bile and saliva of patients with PBC, suggesting that AMA are secreted into the luminal fluid across bile ducts and salivary glands. These data prompted us to determine whether AMA of the IgA isotype may be transported across other epithelial mucosa. Therefore, we tested for the presence of AMA in the urine specimens of 83 patients with PBC and 58 non-PBC controls including healthy individuals and patients with other liver diseases. Patients enrolled in this study had no history of renal disease, and we confirmed there was less than 50 μg/mL of protein in each of the urine specimens. Interestingly, we found that AMA were present in the urine of 71/83 (86%) of all patients with PBC and in 71/78 (91%) of patients with PBC that were serum AMA positive. In contrast, AMA were not detected in any of the 58 control urine specimens. Of particular interest, AMA of the IgA isotype was present in 57/83 (69%) of patients with PBC, and in 52 of these 57, we found secretory-type IgA. In a nested random subgroup of urine samples, the prevalence of the IgA2 AMA was 6/18 (33%), significantly lower than in matched serum samples, 13/16 (81%, P = .007). These data show that AMA of the IgA isotype is secreted into urine from the uroepithelium of patients with PBC, and support the thesis that PBC originated from either a mucosal challenge or a loss of mucosal tolerance.

AB - We have shown that IgA-class antimitochondrial autoantibodies (AMA) can be detected in the bile and saliva of patients with PBC, suggesting that AMA are secreted into the luminal fluid across bile ducts and salivary glands. These data prompted us to determine whether AMA of the IgA isotype may be transported across other epithelial mucosa. Therefore, we tested for the presence of AMA in the urine specimens of 83 patients with PBC and 58 non-PBC controls including healthy individuals and patients with other liver diseases. Patients enrolled in this study had no history of renal disease, and we confirmed there was less than 50 μg/mL of protein in each of the urine specimens. Interestingly, we found that AMA were present in the urine of 71/83 (86%) of all patients with PBC and in 71/78 (91%) of patients with PBC that were serum AMA positive. In contrast, AMA were not detected in any of the 58 control urine specimens. Of particular interest, AMA of the IgA isotype was present in 57/83 (69%) of patients with PBC, and in 52 of these 57, we found secretory-type IgA. In a nested random subgroup of urine samples, the prevalence of the IgA2 AMA was 6/18 (33%), significantly lower than in matched serum samples, 13/16 (81%, P = .007). These data show that AMA of the IgA isotype is secreted into urine from the uroepithelium of patients with PBC, and support the thesis that PBC originated from either a mucosal challenge or a loss of mucosal tolerance.

UR - http://www.scopus.com/inward/record.url?scp=0033754620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033754620&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 910

EP - 915

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -